======= RNF165 ======= == Gene Information == * **Official Symbol**: RNF165 * **Official Name**: ring finger protein 165 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=494470|494470]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q6ZSG1|Q6ZSG1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RNF165&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RNF165|Open PubMed]] * **OMIM**: N/A == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: E3 ubiquitin-protein ligase that acts as a regulator of motor axon elongation. Required for efficient motor axon extension in the dorsal forelimb by enhancing the transcriptional responses of the SMAD1/SMAD5/SMAD8 effectors, which are activated downstream of BMP. Acts by mediating ubiquitination and degradation of SMAD inhibitors such as SMAD6, SMAD7, SKI and SNON isoform of SKIL. {ECO:0000250|UniProtKB:E9QAU8}. |zf-C3HC4| |zf-rbx1| |innervation| |motor neuron axon guidance| |positive regulation of BMP signaling pathway| |multicellular organism aging| |forelimb morphogenesis| |nerve development| |regulation of BMP signaling pathway| |positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway| |limb morphogenesis| |appendage morphogenesis| |limb development| |appendage development| |ubiquitin protein ligase activity| |regulation of transmembrane receptor protein serine/threonine kinase signaling pathway| |axon guidance| |neuron projection guidance| |regulation of cellular response to growth factor stimulus| |aging| |protein polyubiquitination| |axonogenesis| |axon development| |cell morphogenesis involved in neuron differentiation| |muscle structure development| |neuron projection morphogenesis| |plasma membrane bounded cell projection morphogenesis| |cell projection morphogenesis| |cell part morphogenesis| |chemotaxis| |taxis| |cell morphogenesis involved in differentiation| |protein-containing complex| |neuron projection development| |protein catabolic process| |protein ubiquitination| |cell morphogenesis| |protein modification by small protein conjugation| |neuron development| |cellular component morphogenesis| |zinc ion binding| |protein modification by small protein conjugation or removal| |neuron differentiation| |macromolecule catabolic process| |organonitrogen compound catabolic process| |plasma membrane bounded cell projection organization| |cell projection organization| |locomotion| |generation of neurons| |movement of cell or subcellular component| |neurogenesis| |cell development| |positive regulation of signal transduction| |organic substance catabolic process| |positive regulation of cell communication| |positive regulation of signaling| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp379|MSC2530818 10μM R07 exp379]]|-2.25| |[[:results:exp426|FBS-Wisent 0.1 R07 exp426]]|-1.98| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|-1.94| |[[:results:exp465|Cannabidiol 13μM R08 exp465]]|-1.74| |[[:results:exp456|Benzoate 20000μM R08 exp456]]|1.75| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|1.77| |[[:results:exp123|GSK-LSD1 10μM R03 exp123]]|2.19| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13680 * **Expression level (log2 read counts)**: 2.84 {{:chemogenomics:nalm6 dist.png?nolink |}}